+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Urothelial Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Urothelial Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 170 Pages
  • Global
From
From
From
Diabetic Retinopathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Diabetic Retinopathy Treatment - Global Strategic Business Report

  • Report
  • December 2025
  • 273 Pages
  • Global
From
From
Allergy Diagnostics and Therapeutics Market Forecast to 2033 - Product Thumbnail Image

Allergy Diagnostics and Therapeutics Market Forecast to 2033

  • Report
  • October 2025
  • 150 Pages
  • Global
From
From
Osteoporosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Osteoporosis Therapeutics - Global Strategic Business Report

  • Report
  • December 2025
  • 340 Pages
  • Global
From
Immuno-Oncology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Immuno-Oncology Clinical Trials Market Report 2023-2033

  • Report
  • September 2023
  • 249 Pages
  • Global
From
Immunotoxins - Global Strategic Business Report - Product Thumbnail Image

Immunotoxins - Global Strategic Business Report

  • Report
  • December 2025
  • 377 Pages
  • Global
From
From
Rare Hemophilia Factors Market 2024-2028 - Product Thumbnail Image

Rare Hemophilia Factors Market 2024-2028

  • Report
  • July 2024
  • 142 Pages
  • Global
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • December 2025
  • 181 Pages
  • Global
From
Loading Indicator